New data suggest clinicians should think twice before foregoing contrast-enhanced imaging

Although contrast conservation efforts have been widespread across the imaging community since the ICM shortage of 2022 took hold, new data suggest that foregoing contrasted studies in favor of unenhanced imaging could be consequential for patients. 

Published in JAMA Surgery, the new data highlight a potential pitfall of unenhanced CT scans on patients presenting to emergency departments with acute abdominal pain—an inaccurate workup. In these cases, foregoing contrasted CT exams can reduce diagnostic accuracy by up to 30%, authors of the new paper revealed. 

“In a general population of emergency department patients with abdominal pain, using unenhanced CT to avoid risks of intravenous contrast medium administration was associated with a large diagnostic penalty,” study co-author Hiram Shaish, MD, with the Department of Radiology at Columbia University in New York, and colleagues explained. 

For the study, the team analyzed the cases of 201 consecutive adult ED patients who underwent dual-energy contrast-enhanced CT for the evaluation of acute abdominal pain. Three blinded radiologists read the enhanced exams to establish a reference standard by majority rule. The team then used dual energy techniques to digitally subtract the contrast media from those same exams, which were subsequently interpreted by six different blinded radiologists (three specialist faculty and three residents). 

Overall accuracy of the unenhanced exams was recorded as 70%, with the faculty achieving slightly higher scores for primary diagnoses. However, for actionable secondary diagnoses, residents recorded slightly better accuracy. This was because faculty made fewer false negative primary diagnoses, but more false positive secondary diagnoses, the team noted. Both false negative and false positive diagnoses were common with the unenhanced exams. 

The use of contrasted imaging has to be weighed carefully both from an operational standpoint and within the realm of patient care as well, as ICM use carries risks of allergic reactions, hypersensitivity and kidney injury. However, there is no mistaking the diagnostic benefits associated with contrast-enhanced imaging, the team suggested, later adding that providers must strike a balance between these benefits and risks, especially in patients who are more vulnerable to adverse events or reactions. 

The study abstract is available here. 

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She joined Innovate Healthcare in 2021 and has since put her unique expertise to use in her editorial role with Health Imaging.

Around the web

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

Trimed Popup
Trimed Popup